Conference Coverage
Latest News
Which populations should be screened for cervical cancer?
Whether you are a cisgender woman or a transgender man who has kept his uterus, regardless of the sex of your partner, and even if you are a woman...
Latest News
Long-term maintenance required in melasma patients
To optimize results following the laser treatment of melasma, Dr. Arisa Ortiz uses one application of clobetasol immediately after the procedure...
Conference Coverage
Six obstacles in breast cancer detection and treatment
Novel and effective therapies can make a difference only if patients have access to them, oncologists say.
Conference Coverage
Most women with breast cancer elude serious COVID-19 vaccine side effects
The frequency of lymph node swelling was similar to the general population.
Conference Coverage
Breast cancer diagnoses worse among Hispanics during COVID-19 pandemic
A study in San Antonio suggests low insurance coverage rates may be at least partially to blame.
Conference Coverage
Structural racism tied to later-stage breast cancer diagnoses
Black patients were more likely to be diagnosed with triple-negative breast cancer than White patients.
Conference Coverage
Adjuvant chemo tied to better survival in low-risk node-positive breast cancer
The survival advantage was present in all patients under 50 years old.
Conference Coverage
Breast conservation safe option in multisite breast cancer
After 5 years of follow-up, just 3% of women experienced a local recurrence.
Conference Coverage
Women can safely interrupt endocrine therapy to pursue pregnancy
The study included more than 500 premenopausal women from 20 countries who received at least 18 months of endocrine therapy for HR+ breast cancer...
Conference Coverage
Capivasertib/fulvestrant improves progression free survival in breast cancer
The combination of the investigational AKT inhibitor capivasertib and estrogen receptor antagonist fulvestrant, doubled progression-free survival...
Conference Coverage
Gene signature may spare some breast cancer patients from radiation
The POLAR 16-gene mRNA signature accurately identified patients who were unlikely to benefit from radiotherapy after breast-conserving surgery.